Şunu aradınız:: eflornit (Letonca - İngilizce)

vaniqa 11, 5% kr ms (eflornit ns)
vaniqa 11.5% cream (eflornithine)

akt v viela ir eflornit ns (eflornithine).
the active substance is eflornithine.

vaniqa 11, 5% kr ms eflornit ns (eflornithine)
vaniqa 11.5% cream eflornithine

eflornit na pusizdal šan s laiks plazm stabil st vokl bija aptuveni 8 stundas.
the steady state plasma half-life of eflornithine was approximately 8 hours.

z d šana: nav inform cijas par to, vai eflornit ns izdal s cilv ka pien.
lactation: it is not known if eflornithine is excreted in human milk.

nav inform cijas, ka eflornit ns metaboliz tos, un tas izdal s galvenok rt ar ur nu.
eflornithine is not known to be metabolised and is eliminated primarily in the urine.

ja jums ir paaugstin ta jut ba (aler ija) pret eflornit nu vai k du citu vaniqa sast vda u.
if you are allergic (hypersensitive) to eflornithine or to any of the other ingredients.

eflornit ns neatgriezeniski kav ornit ndekarboksil zi, fermentu, kas ir iesaist ts matu stumbra veidošan, ko veic mata folikuls.
eflornithine irreversibly inhibits ornithine decarboxylase, an enzyme involved in the production of the hair shaft by the hair follicle.

stabil st vokl eflornit na iek šana caur du no vaniqa uz sejas das sieviet m, kas skujas, bija 0, 8%.
steady state cutaneous penetration of eflornithine in women from vaniqa on facial skin of shaving women was 0.8%.

katrs grams vaniqa 11, 5% kr ma satur 115 mg eflornit na (hidrohlor da monohidr ta veid).
each gram of vaniqa 11.5% cream contains 115 mg of eflornithine (as hydrochloride monohydrate).

eflornit na stabil st vok a maksim l s un minim l s koncentr cijas plazm attiec gi bija aptuveni 10 ng/ ml un 5 ng/ ml.
the steady state peak and trough plasma concentrations of eflornithine were approximately 10 ng/ ml and 5 ng/ ml, respectively.

katrs grams vaniqa 11, 5% kr ma satur 115 mg eflornit na (eflornithine) (hidrohlor da monohidr ta veid).
each gram of vaniqa 11.5% w/ w cream contains 115 mg eflornithine (as hydrochloride monohydrate).

tom r, ja uz das ir aplic ta oti liela deva vai kr ms nejauši lietots peror li, ir j piev rš v r ba ietekm m, kas nov rojamas pie intravenozaj m terapeitiskaj m eflornit na dev m (400 mg/ kg/ dien, jeb aptuveni 24 g/ dien), k das lieto rst jot trypanosoma brucei gambiense infekciju (frikas miega slim bu): matu izkrišana, sejas uzt kums, l kmes, dzirdes trauc jumi, ku a un zarnu darb bas trauc jumi, stgribas zudums, galvass pes, v jums, reibo i, an mija, trombocitop nija un leikop nija.
however, should very high dose cutaneous administration or accidental oral ingestion occur, attention should be paid to the effects seen with therapeutic doses of intravenous eflornithine (400 mg/ kg/ day or approximately 24 g/ day) used in the treatment of trypanosoma brucei gambiense infection (african sleeping sickness): hair loss, facial swelling, seizures, hearing impairment, gastrointestinal disturbance, loss of appetite, headache, weakness, dizziness, anaemia, thrombocytopenia and leucopenia.